DICKINSON ANDREW D (EVP, Chief Financial Officer) sold 1.8% of their position (3K shares) of GILEAD SCIENCES, INC. on the open market
Open‑market sale worth $415.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/18/2026ACC: 0001310204-26-000024
Officer· EVP, Chief Financial Officer
Since Nov 2019
-3K
Net shares
Net seller
$415.1K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
3K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−3K
Price / share
$138.36
Trade value
$415.08K
% of position
1.8%
8/17/2026
168.65K→165.65K
Total
Net shares
−3K
Net value
-$415.08K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/17/2026 | S · Sale | −3K | $138.36 | $415.08K | 1.8% | 168.65K | 165.65K |
| Total | −3K | -$415.08K | ||||||
Derivative Transactions0
No derivative transactions reported